MILAN, May 21- Italian investment holding company Exor said on Thursday it would not raise its $6.8 billion takeover offer for PartnerRe but was willing to negotiate with the reinsurer if its board declared its offer superior to that of rival suitor Axis Capital Holdings. Bermuda- based PartnerRe said on Wednesday it was ready to talk to Exor, to see if there was...» Read More
The focus for Hostess has now turned to selling its assets and its 30 brands, reports CNBC's Kayla Tausche.
Hostess says it is speaking with more than 110 parties that are interested in buying its brands. CNBC's Kayla Tausche reports.
Is Deckers, the maker of Uggs, Target's next takeover target? The Fast Money traders, weigh in; and Thom Blischok, Booz & Co. chief retail analyst, discusses which retailers are making big moves in mobile and online this holiday season.
According to the WSJ, Advanced Micro is not pursuing a sale of its company or significant assets, reports CNBC's Brian Shactman.
CNBC's David Faber reports the latest detail on Sprint's takeover of Clearwire; and weighs in on Verizon's earnings.
CNBC's Robert Frank says Ellison's reported interest in bidding on AEG, which owns a piece of the Lakers, is in very preliminary stages. Mark Martiak, Premier Wealth Management, provides perspective.
P&G has been one of the great growth companies of all times but quite frankly it has stumbled over the past couple of years under the current CEO's leadership, said William Ackman, Pershing Square Capital Management founder & CEO, discussing the problems at Procter & Gamble.
In this excerpt from a "Squawk Box" interview on October 2, 2012, Pershing Square's Bill Ackman said he had bought some stock and expressed his concerns about the company to its Board.
In court documents that lawyers for Bain Capital sought to keep secret, the company and other leading private equity firms are depicted as unofficial partners in a bid-rigging conspiracy aimed at holding down the prices of businesses they were seeking to buy, The New York Times reports.
Dinakar Singh, TPG-Axon Capital CEO, discusses the best way to play the health care space.
Dinakar Singh, TPG-Axon Capital CEO, discusses the best way to trade financials after the banking crisis.
"Ultimately, I don't think lower rates make that much difference anymore," says Dinakar Singh, TPG-Axon Capital CEO, sharing his thoughts on additional Fed easing.
The co-founder of the trailblazing private-equity firm Kohlberg Kravis Roberts is actively involved in managing the firm famous for its leveraged buyout of RJR Nabisco 25 years ago.
CNBC's David Faber reports the latest details on GlaxoSmithKline's takeover bid for Human Genome Science.
Here are five companies that could be bought, according to analyst Ken Hackel of CT Capital, best known for his book, “Security Valuation and Risk Analysis.”
CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.
CNBC's Kayla Tausche reports Grupo Modelo has confirmed it is in talks on expanding its relationship with Anheuser-Busch.
CNBC's David Faber speaks to activist investor Carl Icahn regarding how much cash he has available to invest and whether Chesapeake Energy is undervalued.
Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC's Herb Greenberg.
CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.